Schrödinger's computational platform holds strategic value, but the financial profile remains challenged by a fixed cost base that has produced operating losses in ten consecutive quarters, with cumulative operating losses exceeding $400M. Revenue growth has b...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $0.08+119.3% vs -$0.41 | $59M+24.8% vs $47M |
Q2 2026 May 5, 2026 | -$0.81-44.6% vs -$0.56 | $59M+23.2% vs $48M |
Q1 2026 Feb 25, 2026 | $0.44+438.5% vs -$0.13 | $87M+4.1% vs $84M |
Q4 2025 Nov 5, 2025 | -$0.45+40.0% vs -$0.75 | $54M-35.0% vs $84M |
Schrödinger, Inc. has undergone significant changes, including pipeline cuts and a strategic pivot away from solo clinical development. Despite software growth deceleration and pipeline setbacks, SDGR's financials improved with the Ajax sale and a stronger balance sheet. SDGR's net income turned positive in Q2 2026, aided by a $48.9M gain from Ajax and increased cash reserves to $418.8M.
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on September 13, 2026, the company granted restricted stock units (RSUs) with respect to 2,243 shares of the company's common stock to three newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company's board of directors, and were made as a material inducem.
Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Benchmark SDGR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Schrödinger, Inc. (SDGR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $30.70 | $2.29B | -21.77 | 23.29% | -40.36% | -26.29% | — | |
| $4.05 | $2.12B | -2.81 | 26.92% | -945.92% | -50.41% | — | |
| $10.71 | $1.81B | -12.75 | -38.24% | -7756.37% | -59.21% | — | |
| $19.35 | $3.39B | -12.02 | 53.44% | -2763.64% | -42.27% | — | |
| $302.95 | $83.56B | 74.62 | 14.12% | 23.61% | 22.88% | — | |
| $8.83 | $1.37B | -883.00 | 8.75% | -16.75% | -6.66% | — |
Schrödinger, Inc. (SDGR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Schrödinger, Inc. (SDGR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jun 29, 2026·SEC
Jun 23, 2026·SEC
Get notified when SDGR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Schrödinger, Inc. (SDGR) stock FAQ — growth, dividends, profitability & financials explained
Schrödinger, Inc. (SDGR) reported $259.0M in revenue for fiscal year 2025. This represents a 365% increase from $55.7M in 2017.
Schrödinger, Inc. (SDGR) grew revenue by 23.3% over the past year. This is strong growth.
Schrödinger, Inc. (SDGR) reported a net loss of $54.3M for fiscal year 2025.
Schrödinger, Inc. (SDGR) has a return on equity (ROE) of -26.3%. Negative ROE indicates the company is unprofitable.
Schrödinger, Inc. (SDGR) had negative free cash flow of $49.8M in fiscal year 2025, likely due to heavy capital investments.
